Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation

NCT06354179 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT06354179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06354179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation
Lead sponsor
University Hospital, Limoges
Phase
Phase 4
Overall status
Recruiting
Start date
April 15, 2025
Completion date
April 15, 2028
Enrollment
162 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression, liver transplantation